Nundina › Discover calendars › FDA New Drug Approvals calendar › FDA approves Pixclara (floretyrosine f-18)FDA approves Pixclara (floretyrosine f-18)11 September 2026The FDA approved Pixclara (floretyrosine f-18), a drug from Telix. Form: Solution, Intravenous. Granted priority review, reserved for treatments that would be a significant improvement over what exists. Application NDA218592.FDA New Drug Approvals calendarMore from this calendar

19 October 2026 - FDA approves Calrezdy (calcuim chloride)

19 October 2026 - FDA approves Cienby (sodium ctirate)

16 October 2026 - FDA approves Yulzety (rivaroxaban)

16 October 2026 - FDA approves Brytly (brytly (apraclonidine))

15 October 2026 - FDA approves Evoxac (cevimeline hydrochloride)